Target Name: RGS9
NCBI ID: G8787
Review Report on RGS9 Target / Biomarker Content of Review Report on RGS9 Target / Biomarker
RGS9
Other Name(s): regulator of G protein signaling 9 | Regulator of G-protein signaling 9 (RGS9) | Regulator of G-protein signaling 9 (isoform 1) | regulator of G-protein signalling 9 | Regulator of G-protein signalling 9 | PERRS | RGS9_HUMAN | Regulator of G protein signaling 9, transcript variant 1 | RGS9L | RGS9 variant 1 | Regulator of G-protein signaling 9

Regulation of GPCRs: RGS9's Role in Cellular Signaling

G protein-coupled receptors (GPCRs) are a family of transmembrane proteins that play a crucial role in cellular signaling. GPCRs are involved in a wide range of physiological processes, including sensory perception, neurotransmission, and hormone signaling. One of the key regulators of GPCRs is RGS9, which is a protein that was discovered as a potential drug target and has since been shown to play a critical role in a variety of cellular processes.

RGS9 is a protein that is expressed in many different tissues and cells, including neurons, muscle cells, and the heart. It is a key regulator of GPCRs, which are a family of transmembrane proteins that play a crucial role in cellular signaling. GPCRs are involved in a wide range of physiological processes, including sensory perception, neurotransmission, and hormone signaling. RGS9 is responsible for regulating the activity of GPCRs, which allows it to play a critical role in cellular signaling.

One of the key functions of RGS9 is to regulate the activity of GPCRs. This is done through a process called GPCR regulation, which involves the binding of RGS9 to the GPCR. Once bound, RGS9 can cause the GPCR to undergo a conformational change, which can alter its activity. This allows RGS9 to regulate the activity of GPCRs and to play a critical role in cellular signaling.

In addition to its role in regulating GPCRs, RGS9 is also involved in the regulation of other cellular processes. For example, RGS9 has been shown to play a critical role in the regulation of cell death, as well as the regulation of cell growth and the response to stimuli.

RGS9 has also been shown to be involved in a variety of diseases, including cancer, neurodegenerative diseases, and cardiovascular disease. For example, studies have shown that RGS9 is involved in the regulation of the growth and survival of cancer cells, as well as the regulation of neurotransmission in neurodegenerative diseases.

Despite its potential as a drug target, RGS9 is not yet widely studied, and much more research is needed to fully understand its role in cellular signaling. Currently, there are very few drugs that are known to interact with RGS9, and research is needed to develop new treatments that can target this protein.

In conclusion, RGS9 is a protein that is involved in the regulation of GPCRs, which are a crucial family of transmembrane proteins that play a critical role in cellular signaling. RGS9 plays a critical role in regulating the activity of GPCRs and is involved in a variety of cellular processes. Despite its potential as a drug target, RGS9 is not yet widely studied and much more research is needed to fully understand its role in cellular signaling.

Protein Name: Regulator Of G Protein Signaling 9

Functions: Inhibits signal transduction by increasing the GTPase activity of G protein alpha subunits thereby driving them into their inactive GDP-bound form. Binds to GNAT1. Involved in phototransduction; key element in the recovery phase of visual transduction (By similarity)

The "RGS9 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RGS9 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

RGS9BP | RGSL1 | RHAG | RHBDD1 | RHBDD2 | RHBDD3 | RHBDF1 | RHBDF2 | RHBDL1 | RHBDL2 | RHBDL3 | RHBG | RHCE | RHCG | RHD | RHEB | RHEBL1 | RHEBP1 | RHEX | RHNO1 | RHO | Rho GTPase | Rho kinase (ROCK) | RHOA | RHOB | RHOBTB1 | RHOBTB2 | RHOBTB3 | RHOC | RHOD | RHOF | RHOG | RHOH | RHOJ | RHOQ | RHOQP3 | RHOT1 | RHOT2 | RHOU | RHOV | RHOXF1 | RHOXF1-AS1 | RHOXF1P1 | RHOXF2 | RHOXF2B | RHPN1 | RHPN1-AS1 | RHPN2 | RIBC1 | RIBC2 | Ribonuclease | Ribonuclease H | Ribonuclease MRP | Ribonuclease P Complex | Ribosomal protein S6 kinase (RSK) | Ribosomal Protein S6 Kinase, 70kDa (p70S6K) | Ribosomal Protein S6 Kinase, 90kDa | Ribosomal subunit 40S | Ribosome-associated complex | RIC1 | RIC3 | RIC8A | RIC8B | RICH1-AMOT complex | RICTOR | RIDA | RIF1 | RIGI | RIIAD1 | RILP | RILPL1 | RILPL2 | RIMBP2 | RIMBP3 | RIMBP3B | RIMBP3C | RIMKLA | RIMKLB | RIMKLBP2 | RIMOC1 | RIMS1 | RIMS2 | RIMS3 | RIMS4 | RIN1 | RIN2 | RIN3 | RING1 | RINL | RINT1 | RIOK1 | RIOK2 | RIOK3 | RIOK3P1 | RIOX1 | RIOX2 | RIPK1 | RIPK2 | RIPK3 | RIPK4